247 related articles for article (PubMed ID: 27870601)
1. T Cell Immunity to Varicella-Zoster Virus in the Setting of Advanced HIV and Multiple Varicella-Zoster Virus Recurrences.
Bender Ignacio RA; Ramchandani MS; Laing KJ; Johnston CM; Koelle DM
Viral Immunol; 2017; 30(1):77-80. PubMed ID: 27870601
[TBL] [Abstract][Full Text] [Related]
2. Varicella-Zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy.
Weinberg A; Wiznia AA; LaFleur BJ; Shah S; Levin MJ
J Infect Dis; 2004 Jul; 190(2):267-70. PubMed ID: 15216460
[TBL] [Abstract][Full Text] [Related]
3. Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood Vaccination.
Eberhardt CS; Wieland A; Nasti TH; Grifoni A; Wilson E; Schmid DS; Pulendran B; Sette A; Waller EK; Rouphael N; Ahmed R
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321817
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system-immune reconstitution inflammatory syndrome presenting as varicella zoster virus-mediated vasculitis causing stroke.
Teo SY; Raha D; Warren D; Hassan A; Monteiro E
Int J STD AIDS; 2014 Aug; 25(9):683-5. PubMed ID: 24407026
[TBL] [Abstract][Full Text] [Related]
5. Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus.
Park HB; Kim KC; Park JH; Kang TY; Lee HS; Kim TH; Jun JB; Bae SC; Yoo DH; Craft J; Jung S
J Rheumatol; 2004 Nov; 31(11):2151-5. PubMed ID: 15517626
[TBL] [Abstract][Full Text] [Related]
6. Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients.
van Besouw NM; Verjans GM; Zuijderwijk JM; Litjens NH; Osterhaus AD; Weimar W
J Med Virol; 2012 Dec; 84(12):2018-25. PubMed ID: 23080511
[TBL] [Abstract][Full Text] [Related]
7. VZV T cell-mediated immunity.
Weinberg A; Levin MJ
Curr Top Microbiol Immunol; 2010; 342():341-57. PubMed ID: 20473790
[TBL] [Abstract][Full Text] [Related]
8. Immune Correlates of Herpes Zoster in People Living with HIV on Effective Antiretroviral Therapy.
Tovar Salazar A; McKhann A; Chen H; Bosch RJ; Weinberg A
AIDS Res Hum Retroviruses; 2019 Oct; 35(10):890-895. PubMed ID: 31179712
[TBL] [Abstract][Full Text] [Related]
9. Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus.
Laing KJ; Russell RM; Dong L; Schmid DS; Stern M; Magaret A; Haas JG; Johnston C; Wald A; Koelle DM
J Infect Dis; 2015 Oct; 212(7):1022-31. PubMed ID: 25784732
[TBL] [Abstract][Full Text] [Related]
10. Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection.
Schub D; Janssen E; Leyking S; Sester U; Assmann G; Hennes P; Smola S; Vogt T; Rohrer T; Sester M; Schmidt T
J Infect Dis; 2015 Feb; 211(4):600-12. PubMed ID: 25180236
[TBL] [Abstract][Full Text] [Related]
11. Increased incidence of herpes zoster in patients on renal replacement therapy cannot be explained by intrinsic defects of cellular or humoral immunity to varicella-zoster virus.
Rondaan C; de Joode AAE; van Assen S; Bos NA; Westerhuis R; Westra J
Antiviral Res; 2018 Oct; 158():206-212. PubMed ID: 30102958
[TBL] [Abstract][Full Text] [Related]
12. Association between quantitative varicella-zoster virus antibody levels and zoster reactivation in HIV-infected persons.
Pomerantz HS; Xu X; White J; Sunil TS; Deiss RG; Ganesan A; Agan BK; Okulicz JF
AIDS Res Ther; 2018 Dec; 15(1):25. PubMed ID: 30537970
[TBL] [Abstract][Full Text] [Related]
13. Serological and T Cell Responses After Varicella Zoster Virus Vaccination in HIV-Positive Patients Undergoing Renal Dialysis.
Righi E; Carnelutti A; La Rosa A; Sartor A; Tulissi P; Gallo T; Ivaldi F; Bassetti M
Viral Immunol; 2019 Apr; 32(3):151-157. PubMed ID: 30694731
[TBL] [Abstract][Full Text] [Related]
14. Immune evasion as a pathogenic mechanism of varicella zoster virus.
Abendroth A; Arvin AM
Semin Immunol; 2001 Feb; 13(1):27-39. PubMed ID: 11289797
[TBL] [Abstract][Full Text] [Related]
15. Varicella-zoster virus infection in children with underlying human immunodeficiency virus infection.
Gershon AA; Mervish N; LaRussa P; Steinberg S; Lo SH; Hodes D; Fikrig S; Bonagura V; Bakshi S
J Infect Dis; 1997 Dec; 176(6):1496-500. PubMed ID: 9395360
[TBL] [Abstract][Full Text] [Related]
16. Robust gene expression changes in the ganglia following subclinical reactivation in rhesus macaques infected with simian varicella virus.
Arnold N; Meyer C; Engelmann F; Messaoudi I
J Neurovirol; 2017 Aug; 23(4):520-538. PubMed ID: 28321697
[TBL] [Abstract][Full Text] [Related]
17. Varicella-zoster virus-specific immunity after herpes zoster.
Hayward A; Levin M; Wolf W; Angelova G; Gilden D
J Infect Dis; 1991 Apr; 163(4):873-5. PubMed ID: 1849165
[TBL] [Abstract][Full Text] [Related]
18. Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases.
Rondaan C; de Haan A; Horst G; Hempel JC; van Leer C; Bos NA; van Assen S; Bijl M; Westra J
Arthritis Rheumatol; 2014 Nov; 66(11):3122-8. PubMed ID: 25223407
[TBL] [Abstract][Full Text] [Related]
19. Varicella-zoster virus infection in Romanian children infected with the human immunodeficiency virus.
Leibovitz E; Cooper D; Giurgiutiu D; Coman G; Straus I; Orlow SJ; Lawrence R
Pediatrics; 1993 Dec; 92(6):838-42. PubMed ID: 7901834
[TBL] [Abstract][Full Text] [Related]
20. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants.
Hata A; Asanuma H; Rinki M; Sharp M; Wong RM; Blume K; Arvin AM
N Engl J Med; 2002 Jul; 347(1):26-34. PubMed ID: 12097537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
